Main Grants | Affiliated Grants: Uganda, Russia, United States, and Other Countries

Project Number PI Project Dates


MAIN GRANTS

URBAN ARCH (1/5) Administrative Coordinating Core
The Administrative Coordinating Core will ensure that the scientific and programmatic goals of the URBAN ARCH Consortium are achieved with high quality and timeliness.
U24AA020778 Samet 09/20/11- 08/31/21
URBAN ARCH (2/5) Biostatistics and Data Management (BDM) Core
The principal objectives of the Biostatistics and Data Management Core are to provide active statistical collaboration in the design and analysis of each individual study and to develop and maintain an integrated, centralized data management system that may be used by all studies within the URBAN ARCH Consortium.
U24AA020779 Cheng 07/01/11- 06/30/21
URBAN ARCH (3/5) Uganda Cohort TB Preventive Therapy For HIV-Infected Alcohol Users In Uganda: An Evaluation Of Safety Tolerability and Adherence
In this study, 380 HIV-infected drinkers in Uganda will be randomized into two arms to test the safety and tolerability of TB preventive therapy regimens.
U01AA020776 Hahn 09/01/16- 08/31/21
URBAN ARCH (4/5) Russia Cohort – Targeting HIV-Comorbidities With Pharmacotherapy To Reduce Alcohol and Tobacco Use In HIV-Infected Russians
This randomized controlled trial will compare the effects of varenicline, cytisine, and nicotine replacement therapy (NRT) on three major conditions often responsible for mortality and morbidity among people living with HIV.
U01AA020780 Samet/
Freiberg/
Tindle
09/01/16- 08/31/21
URBAN ARCH (5/5) Boston Cohort – Alcohol And HIV-Associated Comorbidity and Complications: Frailty, Functional Impairment, Falls, and Fractures (The 4F Study)
This study will follow the Boston ARCH cohort to better understand falls in people living with HIV and specifically test associations between alcohol and falls, and alcohol and acute healthcare utilization.
U01AA020784 Saitz 09/01/16- 08/31/21
Impact of Heavy Alcohol Use on Pre-ART HIV Disease – Uganda ARCH Cohort
In the Uganda ARCH Cohort, we examined the effect of heavy alcohol consumption on HIV disease progression prior to ART.
U01AA020776 Hahn 09/20/11- 08/31/16
Alcohol and Zinc Impact on Inflammatory Markers in HIV Disease – Russia ARCH Cohort
In the Russia ARCH Cohort, we examined a cohort of HIV-infected heavy drinkers to determine alcohol’s impact on biomarkers reflecting microbial translocation.
U01AA020780 Samet 09/20/11- 08/31/16
Addressing Alcohol/HIV Consequences in Substance Dependence – Boston ARCH Cohort
In the Boston ARCH Cohort, we characterized alcohol use and consequences in people with HIV infection affected by multiple substances, and looked prospectively at the impact on bone health.
U01AA020784 Saitz 09/20/11- 08/31/16
Zinc for HIV Disease among Alcohol Users – An RCT in the Russia ARCH Cohort
This double-blinded randomized controlled trial will assess the efficacy of zinc supplementation vs. placebo among 250 HIV-infected Russians, who are ART-naïve at enrollment and have a recent history of heavy drinking.
U01AA021989 Samet/
Freiberg
09/25/12- 08/31/17

Affiliated Grants

Uganda
Interventions to Reduce Alcohol Use and Increase Adherence to TB Preventive Therapy Among HIV/TB Co-infected Drinkers (DIPT 1/2)
The goal of this study is to test an intervention in which participants will receive a reward for reduced alcohol intake and for have been adherent to INH treatment, to see whether this will reduce alcohol use and increase adherence to TB preventative therapy.
U01AA026223-01 Hahn 9/15/17- 8/31/22
Alcohol Epidemiology and Pilot Intervention to Reduce Alcohol, IPV and HIV in Women in Uganda
The purpose of this career development award is to research women with co-morbid alcohol use disorders and intimate partner violence (IPV) victimization, at risk for acquiring HIV (or already infected) and pilot test an HIV clinic-based alcohol and IPV reduction intervention.
K01AA024068 Wagman 08/20/15- 07/31/20
Training in Research Program on Alcohol Use by Persons-with-or-at-Risk for HIV
The objective of this K24 is to mentor investigators from USCF and Uganda in patient-oriented alcohol/HIV research.
K24AA022586

Hahn

09/15/13- 08/31/18
Alcohol Use And High Risk Behavior Among HIV-Positive Men
The goal of this study is to gain a better understanding of the relationship between event-level alcohol use and high risk behavior among HIV-positive drinkers. These findings will help to develop a behavioral HIV prevention intervention.
K01AA021671 Woolf-King
09/06/13
08/31/18
Changes in Alcohol Consumption in HIV Positives in Uganda
The goal of this study is to examine changes in alcohol consumption in the course of HIV care in Uganda. We are using novel biomarkers of alcohol consumption to gain objective measurements of alcohol consumption, as well as in-depth interviews to examine reasons for changes in alcohol consumption.
R01AA018631 Hahn
07/15/10- 03/31/14
Feasibility of Screening and Brief Intervention for Hazardous Alcohol Use amongst HIV-infected Adults in Uganda: A Qualitative Study
This qualitative study will describe the feasibility of using SBI to reduce hazardous alcohol use in HIV infected adults in Uganda in order to develop a strategy to reduce hazardous alcohol use.
UCSF CFAR Int’l Mentored Scientist Asiimwe/
Hahn
7/1/15- 6/30/16
Proof of Concept of a Self-Administered Digital Health Screener (SASH) to Increase Reporting of Unhealthy Alcohol Use by Persons with HIV in Care in Uganda
The objective of this study is to develop and pilot a brief (3-5 minute) self-administered digital health screener (SASH) embedded within a general health screener in an HIV clinic waiting area in order to increase the reporting of unhealthy alcohol consumption.
UCSF CFAR Est. Investigator Award Hahn 3/16/16- 3/15/17
Russia
Pilot Study of Opioid-receptor Antagonists to Reduce Pain and Inflammation among HIV-Infected Persons with Alcohol Problems
This study will pilot test novel pharmacotherapies (opioid receptor antagonists) to improve chronic pain among HIV-infected heavy drinkers, and will explore the hypothesis that the mechanism of action for improving pain is through decreased inflammation.
UH2AA026193-01 Samet/
Tsui
9/20/17- 8/31/19
ST. PETER HIV-Alcohol, Protein Biomarkers and Cardiovascular Disease Risk
This study will draw HIV infected participants from the St PETER HIV trial to assess whether heavier alcohol use is associated with increased trimethylamine N-oxide (TMAO), and subsequently whether increased TMAO levels are associated with subclinical measures and biomarkers of heart failure.
R01AA025859-01 Samet/
Freiberg
09/15/17- 08/31/20
1/2 Alcohol Associated Comorbidities and Microbiome Evaluation in HIV (ACME HIV)
This study will draw HIV infected participants from the St PETER HIV trial to determine if alcohol consumption changes the type of bacteria that are present in the gut. We will then determine if these changes in the bacteria of the gut are associated with changes in gut leakiness, levels of inflammation in the blood, and changes in the structure and function of the heart.
U01AA026222-01 Freiberg 08/1/17-
07/31/22
Zinc for HIV Disease among Alcohol Users – An RCT in the Russia ARCH Cohort – Gender Supplement
The goal of this supplement is to 1) conduct sex/gender comparative analyses using existing data from Russia ARCH/ZINC cohort and 2) evaluate the feasibility and appropriateness of implementing Pre-exposure Prophylaxis (PrEP) among uninfected partners of HIV-infected participants. See here for the aims of this supplement.
U01AA021989-05S1 Samet/
Freiberg
09/15/16-08/31/18
Stigma, Risk Behaviors And Health Care Among HIV-Infected Russian People Who Inject Drugs
In this pilot study, SCRIPT (Stigma Coping to Reduce HIV risks and Improve substance use Prevention and Treatment) data will be examined to determine factors affecting double stigma and its role in substance use and health care utilization among HIV-infected PWID in Russia.
K99DA041245 Lunze 06/01/16-
05/31/18
National Institute on Drug Abuse (NIDA) International Visiting Scientists and Technical Exchange Program (INVEST) Drug Abuse Research Fellowship
Dr. Bulat Idrisov from Russia will work under the mentorship of Dr. Jeffrey Samet researching food insecurity and behavioral risk factors in the Russia ARCH Cohort and honing his skills as an addiction researcher.
NIDA INVEST Fellowship Samet/
Idrisov
03/01/16- 4/30/17
Liver’s Immune Involvement with Ethanol Re-examined in HIV – LIVER HIV
Dr. Kaku So-Armah will be funded by this NIAAA Diversity Supplement to examine the role of liver disease, alcohol, and immune dysfunction in the Russia ZINC study. See here for the aims of this supplement.
U01AA021989 So-Armah 9/2014-8/2016
Examining Association between Alcohol Consumption and HIV on Adaptive Immune Dysfunction Utilizing Flow Cytometry
This administrative supplement allowed us to perform flow cytometry testing on CD profiles for all 250 Russia ARCH Cohort participants at baseline and one follow up time point in order to determine the association between alcohol consumption and HIV on biomarkers of adaptive immune dysfunction over time in a cohort of HIV infected Russian men and women who are antiretroviral (ART) naïve at the time of enrollment. See here for the aims of this supplement.
Supplement to U01AA020780 Samet 02/01/13- 08/31/14
Study Attrition Among HIV-infected Russian Risky Drinkers
The goal of this study was to identify factors associated with attrition among HIV-infected risky drinkers and if current risky behaviors were a predictor of attrition.
NIDA INVEST
Fellowship
Kiriazova 12/01/12 11/30/13
Clinical Impact of Drug Use in HIV-Infected Persons: A Pilot Study
The goal of this pilot study, Drug Use IMPACT (Investigating and Measuring Progression to AIDS in a Cohort Trial), was to begin to investigate the relationship between drug abuse and HIV disease progression by utilizing a current cohort of HIV-infected adults in Russia.
R21DA025435 Samet 09/01/08- 08/31/11
Maximizing Opportunity – HIV Prevention in Hospitalized Russian Drinkers
The objective of this grant, HERMITAGE, HIV’s Evolution in Russia – Mitigating Infection Transmission and Alcoholism in a Growing Epidemic, was to test in a randomized controlled trial the effectiveness of a modified U.S. HIV secondary prevention program, Healthy Relationships Intervention, among HIV-infected patients with risky drinking in Russian infectious disease hospitals.
R01AA016059 Samet 09/30/06- 02/28/13
HIV Prevention Partnership in Russian Alcohol Treatment
The purpose of this proposal was to develop the infrastructure in St. Petersburg, Russia to develop and test an HIV prevention intervention for alcohol and drug dependent persons based in a narcology hospital.
R21AA014821 Samet 09/29/03- 08/31/07
United States
Internet-Based Video Conferencing to Address Alcohol Use and Pain Among Heavy Drinkers in HIV-Care
This UH2 seeks to develop a novel, integrated behavioral approach to reduce heavy drinking and chronic pain among patients in HIV-care delivered via internet-based videoconferencing.
UH2AA026192 Palfai 9/15/17- 8/31/19
Implementing Pre-Exposure Prophylaxis for HIV Prevention among People Who Inject Drugs
This objective of this K01 is to develop a community- based PrEP intervention for people who inject drugs (PWID).
K01DA043412 Bazzi 4/1/17-
3/31/22
Novel Mechanisms Driving Excess Atherosclerotic Cardiovascular Disease Risk in the Context of HIV: The Role of Liver Injury
This K01 seeks to understand whether the excess risk for heart disease is caused by the high levels of liver injury often seen in HIV. Identifying the role that liver injury plays may have important implications for the ability to predict who is at increased risk for developing heart disease and finding effective ways to reduce this risk
K01HL134147 So-Armah 08/01/16- 07/31/21
Optimizing Bio-behavioral HIV Prevention Approaches for People Who Inject Drugs
This collaborative project will adapt and refine a theory-based intervention to optimize PrEP uptake and adherence for people who inject drugs (PWID) in Boston, MA and Providence, RI.
Providence/LIfespan CFAR Bazzi/
Biello
03/01/16- 02/28/17
Effects of Alcohol and Opioid Consumption on Bone Turnover Markers
This administrative supplement allowed us to examine the effects of alcohol and opioid consumption on bone turnover markers (BTMs) in the Boston ARCH Cohort. See here for the aims of this supplement.
U01AA020784-04S1 Saitz/
Kim
12/01/14-08/31/16
Facilitated Access to Substance Abuse Treatment with Prevention and Treatment of HIV
The objective of this grant was to expand and enhance capacity for treatment of alcohol and drug dependence among HIV-infected and HIV-uninfected individuals in conjunction with comprehensive HIV/AIDS treatment and prevention services.
1H79TI018710 Walley 09/30/07- 09/29/12
Clinical Impact of HCV and Alcohol in HIV-Infected Persons
The objective of this project was to test whether alcohol consumption and HCV, separate and together, are associated with worse HIV-related disease outcomes and to determine the magnitude and importance of these effects.
R01AA13216 Samet 09/26/00- 07/31/05
Other Countries
Effect of Alcohol Intake on Intestinal Permeability, Systemic Inflammation and Oxidative Stress: Longitudinal Study of Patients with Alcohol Use Disorder with or without Co-occurring Use of Cannabis and/or Cocaine 2015I027
Ministry of Health, Spain
Fuster 02/01/16 01/31/19
Double Stigma as Barrier to Integrated HIV Treatment among HIV-Infected PWID in Ukraine
The purpose of this pilot study aims is to examine the double stigmas of HIV and substance use as a barrier to treatment integration among HIV-infected people who inject drugs (PWID) in Ukraine.
Providence/LIfespan CFAR Lunze
Integrating Alcohol SBI into HIV Counseling and Testing
This is a trial to test the short-term efficacy of implementing screening and brief intervention (SBI) to reduce alcohol consumption in patients receiving HIV care in a military hospital in sub-Saharan Africa.
N00244-13-1-0048 Hahn 08/28/13- 08/27/18